1.
Lancet Reg Health Southeast Asia
; 11: 100158, 2023 Apr.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37384365
2.
BMJ
; 378: e069506, 2022 07 13.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35830982
3.
Front Public Health
; 9: 699918, 2021.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34527649
4.
Open Med (Wars)
; 16(1): 1168-1169, 2021.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34435142
RESUMO
All governments, regulatory authorities, and vaccine-related committees are under tremendous pressure to roll out vaccines to safeguard the people against COVID-19. To be noted that all COVID-19 vaccines have been developed hurriedly, some with new technologies being used on humans for the first time ever. Most clinical trials did not include elderly patients with comorbidities, hence a careful and logical rollout planning, especially for elderly people, is necessary.